ESTABLISHMENT OF HUMAN GLIOMA CELL-LINES WITH STABLE AND UNSTABLE GFAP EXPRESSION

被引:3
|
作者
ONDA, K
WASHIYAMA, K
TANAKA, R
NISHIYAMA, A
USUI, H
KUMANISHI, T
机构
[1] NIIGATA UNIV,BRAIN RES INST,DEPT NEUROPATHOL,NIIGATA 951,JAPAN
[2] NIIGATA UNIV,BRAIN RES INST,DEPT NEUROSURG,NIIGATA 951,JAPAN
来源
BIOMEDICAL RESEARCH-TOKYO | 1992年 / 13卷 / 05期
关键词
D O I
10.2220/biomedres.13.327
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have established two glial fibrillary acidic protein (GFAP)-positive human glioma cell lines and have analyzed their stability of GFAP expression through successive passages using the immunohistochemistry and Northern blot hybridization. In one cell line (Case 1), the cultured cells showed stable expression of GFAP protein and mRNA from early to later passage levels. Stability of GFAP expression was also shown in all of 8 clones isolated from this cell line. In the other cell line (Case 2), GFAP expression was shown to be less stable. At early passage, nearly 100% of the cultured cells displayed intense GFAP immunoreactivity. After passage 30, however, weakly to negatively stained cells increased gradually in number, and by passage 100, almost all cells had become negative for GFAP. A similar change in GFAP immunoreactivity during successive passages was also observed in each of 7 GFAP-positive clones isolated from this cell line at passages 30 and 50, suggesting that each cell had a tendency to reduce and finally stop its GFAP expression. Northern blot studies revealed that GFAP mRNA also changed concomitantly in the parental and clonal cell lines, suggesting a regulatory change at the transcriptional level. These two cell lines with different features of GFAP expression might be useful for studies on the regulatory mechanism of GFAP expression.
引用
收藏
页码:327 / 334
页数:8
相关论文
共 50 条
  • [1] ESTABLISHMENT OF HUMAN GLIOMA CELL-LINES WITH STABLE AND UNSTABLE GFAP EXPRESSION (BIOMEDICAL RES, VOL 13, PG 327, 1992)
    ONDA, K
    WASHIYAMA, K
    TANAKA, R
    NISHIYAMA, A
    USUI, H
    KUMANISHI, T
    [J]. BIOMEDICAL RESEARCH-TOKYO, 1992, 13 (06): : 455 - 455
  • [2] PROTOONCOGENE EXPRESSION IN HUMAN GLIOMA DERIVED CELL-LINES
    HAMEL, W
    WESTPHAL, M
    SHEPARD, HM
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1992, 1 (06) : 673 - 682
  • [3] ESTABLISHMENT, CHARACTERIZATION AND CHEMOSENSITIVITY OF 2 HUMAN GLIOMA DERIVED CELL-LINES
    ZUPI, G
    CANDILORO, A
    LAUDONIO, N
    CARAPELLA, C
    BENASSI, M
    RICCIO, A
    BELLOCCI, M
    GRECO, C
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1988, 6 (02) : 169 - 177
  • [4] EXPRESSION OF P-GLYCOPROTEIN IN HUMAN GLIOMA CELL-LINES AND SURGICAL GLIOMA SPECIMENS
    MATSUMOTO, T
    TANI, E
    KABA, K
    SHINDO, H
    MIYAJI, K
    [J]. JOURNAL OF NEUROSURGERY, 1991, 74 (03) : 460 - 466
  • [5] AMPLIFICATION AND EXPRESSION OF A MULTIDRUG RESISTANCE GENE IN HUMAN GLIOMA CELL-LINES
    MATSUMOTO, T
    TANI, E
    KABA, K
    KOCHI, N
    SHINDO, H
    YAMAMOTO, Y
    SAKAMOTO, H
    FURUYAMA, J
    [J]. JOURNAL OF NEUROSURGERY, 1990, 72 (01) : 96 - 101
  • [6] PATTERNS OF PROTO-ONCOGENE EXPRESSION IN HUMAN GLIOMA CELL-LINES
    LAROCCA, RV
    WESTERMARK, B
    ISRAEL, MA
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 178 - 178
  • [7] TENASCIN EXPRESSION IN HUMAN GLIOMA CELL-LINES AND NORMAL-TISSUES
    VENTIMIGLIA, JB
    WIKSTRAND, CJ
    OSTROWSKI, LE
    BOURDON, MA
    LIGHTNER, VA
    BIGNER, DD
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1992, 36 (01) : 41 - 55
  • [8] PATTERNS OF PROTO-ONCOGENE EXPRESSION IN HUMAN GLIOMA CELL-LINES
    LAROCCA, RV
    ROSENBLUM, M
    WESTERMARK, B
    ISRAEL, MA
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1989, 24 (01) : 97 - 106
  • [9] ESTABLISHMENT OF ATTACHED AND NON-ATTACHED CELL-LINES FROM AN UNCOMMON HUMAN GLIOMA
    WESTERMARK, B
    LARSSON, E
    BRUNK, U
    LUBITZ, W
    MARK, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1981, 28 (03) : 341 - 351
  • [10] SYNCHRONIZATION OF HUMAN GLIOMA CELL-LINES WITH HYDROXYUREA
    BIEGEL, JA
    BIGNER, SH
    LESLIE, DS
    BIGNER, DD
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1986, 4 (01) : 95 - 95